help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2004-1641
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patterson, M.
Right arrow Articles by Bloom, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patterson, M.
Right arrow Articles by Bloom, S. R.
Related Collections
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 4 2205-2211
Copyright © 2005 by The Endocrine Society

Characterization of Ghrelin-Like Immunoreactivity in Human Plasma

Michael Patterson, Kevin G. Murphy, Carel W. le Roux, Mohammad A. Ghatei and Stephen R. Bloom

Department of Metabolic Medicine, Imperial College Faculty of Medicine, London Hammersmith Hospital, London W12 ONN, United Kingdom

Address all correspondence and requests for reprints to: Professor Stephen R. Bloom, Department of Metabolic Medicine, Imperial College, London Hammersmith Hospital, Du Cane Road, London W12 ONN, United Kingdom. E-mail: s.bloom{at}imperial.ac.uk.

Ghrelin is a gastric peptide hormone that has an important role in appetite control and GH release. Circulating ghrelin levels are inversely correlated with body mass index and postprandially suppressed. However, the molecular form of circulating ghrelin has not been fully characterized. We studied circulating ghrelin-like immunoreactivity (Ghr-LI) using three RIAs: one specific for only the active, acylated ghrelin (antibody G0–1) and the other two detecting both active and inactive, des-acylated ghrelin (antibody SC and the commercially available Phoenix Pharmaceuticals assay). Plasma ghrelin levels were measured in healthy subjects after a test breakfast (n = 8). Ghr-LI detected by SC and the commercial assay fell significantly at 90 and 120 min post meal (P < 0.01). G0–1 Ghr-LI decreased significantly at 30 min (P < 0.05) post meal and had returned to basal levels at 90 min. Gel permeation chromatography identified three Ghr-LI peaks in plasma. Two G0–1 Ghr-LI peaks with a molecular weight much larger than ghrelin peptide were detected. Only one Ghr-LI peak was detected by the SC and commercial RIA, at the same elution position as synthetic des-acylated ghrelin. These results suggest that the majority of circulating acylated ghrelin is bound to larger molecules, whereas des-acylated ghrelin circulates as free peptide. Assays measuring specific forms of ghrelin may be more useful in determining its physiological role than those that detect both acylated and des-acylated forms.




This article has been cited by other articles:


Home page
J. Nutr.Home page
E. J. Stevenson, N. M. Astbury, E. J. Simpson, M. A. Taylor, and I. A. Macdonald
Fat Oxidation during Exercise and Satiety during Recovery Are Increased following a Low-Glycemic Index Breakfast in Sedentary Women
J. Nutr., May 1, 2009; 139(5): 890 - 897.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. Padidela, M. Patterson, N. Sharief, M. Ghatei, and K. Hussain
Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period
Eur. J. Endocrinol., January 1, 2009; 160(1): 53 - 58.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A Rocha-Sousa, P Alves-Faria, I Falcao-Pires, F Falcao-Reis, and A F Leite-Moreira
Analyses of aqueous humour ghrelin levels of eyes with and without glaucoma
Br. J. Ophthalmol., January 1, 2009; 93(1): 131 - 132.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Liu, C. E. Prudom, R. Nass, S. S. Pezzoli, M. C. Oliveri, M. L. Johnson, P. Veldhuis, D. A. Gordon, A. D. Howard, D. R. Witcher, et al.
Novel Ghrelin Assays Provide Evidence for Independent Regulation of Ghrelin Acylation and Secretion in Healthy Young Men
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1980 - 1987.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Bech, V. Winstanley, K. G. Murphy, A. H. Sam, K. Meeran, M. A. Ghatei, and S. R. Bloom
Elevated Cocaine- and Amphetamine-Regulated Transcript Immunoreactivity in the Circulation of Patients with Neuroendocrine Malignancy
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1246 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. R. C. Parkinson, W. S. Dhillo, C. J. Small, O. B. Chaudhri, G. A. Bewick, I. Pritchard, S. Moore, M. A. Ghatei, and S. R. Bloom
PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E698 - E708.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. H St-Pierre, J.-P. Bastard, L. Coderre, M. Brochu, A. D Karelis, M.-E. Lavoie, F. Malita, J. Fontaine, D. Mignault, K. Cianflone, et al.
Association of acylated ghrelin profiles with chronic inflammatory markers in overweight and obese postmenopausal women: a MONET study
Eur. J. Endocrinol., October 1, 2007; 157(4): 419 - 426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. T. Vestergaard, T. K. Hansen, L. C. Gormsen, P. Jakobsen, N. Moller, J. S. Christiansen, and J. O. L. Jorgensen
Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1829 - E1836.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. Martins, L. M Morgan, S. R Bloom, and M D. Robertson
Effects of exercise on gut peptides, energy intake and appetite
J. Endocrinol., May 1, 2007; 193(2): 251 - 258.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Rauh, M. Groschl, and W. Rascher
Simultaneous Quantification of Ghrelin and Desacyl-Ghrelin by Liquid Chromatography-Tandem Mass Spectrometry in Plasma, Serum, and Cell Supernatants
Clin. Chem., May 1, 2007; 53(5): 902 - 910.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. G. Murphy, W. S. Dhillo, and S. R. Bloom
Gut Peptides in the Regulation of Food Intake and Energy Homeostasis
Endocr. Rev., December 1, 2006; 27(7): 719 - 727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. S. Dhillo, P. Savage, K. G. Murphy, O. B. Chaudhri, M. Patterson, G. M. Nijher, V. M. Foggo, G. S. Dancey, H. Mitchell, M. J. Seckl, et al.
Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E878 - E884.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. W. le Roux, R. L. Batterham, S. J. B. Aylwin, M. Patterson, C. M. Borg, K. J. Wynne, A. Kent, R. P. Vincent, J. Gardiner, M. A. Ghatei, et al.
Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
Endocrinology, January 1, 2006; 147(1): 3 - 8.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. S. Dhillo, O. B. Chaudhri, M. Patterson, E. L. Thompson, K. G. Murphy, M. K. Badman, B. M. McGowan, V. Amber, S. Patel, M. A. Ghatei, et al.
Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6609 - 6615.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C D R Murray, N M Martin, M Patterson, S A Taylor, M A Ghatei, M A Kamm, C Johnston, S R Bloom, and A V Emmanuel
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study
Gut, December 1, 2005; 54(12): 1693 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Feinle-Bisset, M. Patterson, M. A. Ghatei, S. R. Bloom, and M. Horowitz
Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E948 - E953.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
O. Gimenez-Palop, G. Gimenez-Perez, D. Mauricio, E. Berlanga, N. Potau, C. Vilardell, J. Arroyo, J.-M. Gonzalez-Clemente, and A. Caixas
Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes
Eur. J. Endocrinol., July 1, 2005; 153(1): 73 - 79.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society